Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Quinton

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|September 1, 2007
Reversal of idiopathic hypogonadotropic hypogonadismTaneli Raivio, John Falardeau, Andrew Dwyer, et al.
Clinical Endocrinology|April 10, 2014
Saving lives of in-patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle-upon-Tyne Hospitals e-Prescribing platformAnna L Mitchell, Catherine Napier, Muhammad Asam, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibilityAlison Sutherland, Jocelyn Davies, Catherine J Owen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2013
Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatmentEarn H Gan, Katie MacArthur, Anna L Mitchell, et al.
Andrology|January 22, 2022
Identifying the outcomes important to men with hypogonadism: A qualitative evidence synthesisMagaly Aceves-Martins, Richard Quinton, Miriam Brazzelli, et al.
Clinical Endocrinology|August 24, 2017
Improving the prehospital safety of steroid-dependent patients in northern England: A hospital-initiated ambulance service registration pathwayAnna L Mitchell, Kerri Devine, Vikram Lal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Oligogenic basis of isolated gonadotropin-releasing hormone deficiencyGerasimos P Sykiotis, Lacey Plummer, Virginia A Hughes, et al.
Molecular and Cellular Endocrinology|June 13, 2006
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypesNelly Pitteloud, Astrid Meysing, Richard Quinton, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine systemValerie F Sidhoum, Yee-Ming Chan, Margaret F Lippincott, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluationMoira Cruickshank, Jemma Hudson, Rodolfo Hernández, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|September 1, 2007
Reversal of idiopathic hypogonadotropic hypogonadismTaneli Raivio, John Falardeau, Andrew Dwyer, et al.
Clinical Endocrinology|April 10, 2014
Saving lives of in-patients with adrenal insufficiency: implementation of an alert scheme within the Newcastle-upon-Tyne Hospitals e-Prescribing platformAnna L Mitchell, Catherine Napier, Muhammad Asam, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibilityAlison Sutherland, Jocelyn Davies, Catherine J Owen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2013
Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatmentEarn H Gan, Katie MacArthur, Anna L Mitchell, et al.
Andrology|January 22, 2022
Identifying the outcomes important to men with hypogonadism: A qualitative evidence synthesisMagaly Aceves-Martins, Richard Quinton, Miriam Brazzelli, et al.
Clinical Endocrinology|August 24, 2017
Improving the prehospital safety of steroid-dependent patients in northern England: A hospital-initiated ambulance service registration pathwayAnna L Mitchell, Kerri Devine, Vikram Lal, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Oligogenic basis of isolated gonadotropin-releasing hormone deficiencyGerasimos P Sykiotis, Lacey Plummer, Virginia A Hughes, et al.
Molecular and Cellular Endocrinology|June 13, 2006
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypesNelly Pitteloud, Astrid Meysing, Richard Quinton, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine systemValerie F Sidhoum, Yee-Ming Chan, Margaret F Lippincott, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluationMoira Cruickshank, Jemma Hudson, Rodolfo Hernández, et al.
Pageof 19